{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:27:58Z","timestamp":1791836878549,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have demonstrated that hepatocyte growth factor (HGF) is implicated in treatment resistance in rheumatoid arthritis (RA). This study aimed to elucidate the mechanistic role of HGF in synovial inflammation and assess the therapeutic potential of targeting the HGF-c-Met axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma HGF levels were measured in 66 RA patients. The expression of HGF and its receptor, c-Met, in synovial tissue was assessed using publicly available single-cell RNA sequencing data and immunostaining. The effects of HGF on synovial fibroblasts were examined through bulk RNA sequencing, immunostaining, and quantitative PCR. The therapeutic efficacy of the c-Met inhibitor savolitinib was evaluated in a mouse model of arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma HGF levels were significantly elevated in RA patients (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0003) and correlated with Disease Activity Score 28-ESR (r = 0.367,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002). Single-cell analysis and immunostaining revealed that HGF was predominantly expressed in monocytes and fibroblasts, while c-Met expression was restricted to synovial fibroblasts. RNA sequencing indicated that HGF stimulation upregulated key inflammatory markers, including IL-6 and HGF itself, in synovial fibroblasts, establishing an inflammatory feedback loop.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , inhibition of the HGF-c-Met pathway with savolitinib significantly suppressed arthritis development and reduced synovial inflammation. Additionally, activation of Toll-like receptor 4 and 5 activation induced HGF production in human monocytes, which may amplify IL-6-mediated inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HGF primarily acts on synovial fibroblasts, driving an IL-6-mediated inflammatory amplification loop that may contribute to therapeutic resistance in RA. Targeting the HGF-c-Met pathway could represent a novel strategy for overcoming treatment refractoriness in RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1718591","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:42:19Z","timestamp":1769755339000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatocyte growth factor as a driver of synovial inflammation and therapeutic resistance in rheumatoid arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Quang Minh","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]},{"name":"Department of Orthopaedic Surgery, College of Health Science, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Sarcoma Center, Vinmec Healthcare System","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Kadoba","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]},{"name":"Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Kurashiki Central Hospital","place":["Kurashiki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Duc","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, College of Health Science, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Sarcoma Center, Vinmec Healthcare System","place":["Hanoi, Vietnam"]},{"name":"Department of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Quang Tran","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, College of Health Science, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Sarcoma Center, Vinmec Healthcare System","place":["Hanoi, Vietnam"]},{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh","family":"Van Nguyen","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]},{"name":"Anatomic pathologist Pathology division of Laboratory Department, Vinmec Healthcare System","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Mamoto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Okano","sequence":"additional","affiliation":[{"name":"Center for Senile Degenerative Disorders (CSDD), Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Trung","family":"Dung","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, College of Health Science, VinUniversity","place":["Hanoi, Vietnam"]},{"name":"Sarcoma Center, Vinmec Healthcare System","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thi Thanh","family":"Thuy","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]},{"name":"Department of Global Education and Medical Sciences, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05349-8","article-title":"Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations","volume":"43","author":"Garcia-Salinas","year":"2023","journal-title":"Rheumatol Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead143","article-title":"Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital","volume":"62","author":"Hecquet","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa860","article-title":"Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab209","article-title":"Characteristics of patients with difficult-to-treat rheumatoid arthritis in real-world","volume":"60","author":"Takanashi","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae265","article-title":"Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study","volume":"63","author":"Watanabe","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/25785826.2021.1928383","article-title":"Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort","volume":"45","author":"Watanabe","year":"2022","journal-title":"Immunol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-023-03236-y","article-title":"Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis","volume":"26","author":"Iwasaki","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901437","article-title":"Dynamics of type I and type II interferon signature determines responsiveness to anti-TNF therapy in rheumatoid arthritis","volume":"13","author":"Iwasaki","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91253-1","article-title":"Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats","volume":"122","author":"Nakamura","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","article-title":"Hepatocyte growth factor: A regulator of inflammation and autoimmunity","volume":"14","author":"Molnarfi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines2040301","article-title":"Hepatocyte growth factor isoforms in tissue repair, cancer, and fibrotic remodeling","volume":"2","author":"Mungunsukh","year":"2014","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-010-0501-0","article-title":"C-MET as a new therapeutic target for the development of novel anticancer drugs","volume":"12","author":"Canadas","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.3390\/ijms19123844","article-title":"HGF\/c-MET signaling in melanocytes and melanoma","volume":"19","author":"Czyz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/030097401316909585","article-title":"Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis","volume":"30","author":"Feuerherm","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390917","article-title":"Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis","volume":"39","author":"Koch","year":"1996","journal-title":"Arthritis Rheumatol"},{"key":"B18","article-title":"Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis","volume":"28","author":"Nagashima","year":"2001","journal-title":"J Rheumatol"},{"key":"B19","article-title":"Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells","volume":"21","author":"Yukioka","year":"1994","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa310","article-title":"Inhibition of hepatocyte growth factor\/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis","volume":"60","author":"Hosonuma","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jot.2020.10.011","article-title":"Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice","volume":"27","author":"Huang","year":"2021","journal-title":"J Orthop Translat"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.3390\/jcm12062342","article-title":"CD8(+) regulatory T cell deficiency in elderly-onset rheumatoid arthritis","volume":"12","author":"Watanabe","year":"2023","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg391","article-title":"Activated leucocytes express and secrete macrophage inflammatory protein-1alpha upon interaction with synovial fibroblasts of rheumatoid arthritis via a beta2-integrin\/ICAM-1 mechanism","volume":"42","author":"Hanyuda","year":"2003","journal-title":"Rheumatol (Oxford)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/ar142","article-title":"Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture\u2013primary culture cells markedly differ from fourth-passage cells","volume":"3","author":"Zimmermann","year":"2001","journal-title":"Arthritis Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts","volume":"4","author":"Pilling","year":"2009","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac958","article-title":"Ensembl 2023","volume":"51","author":"Martin","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.42016","article-title":"Effect of impaired T cell receptor signaling on the gut microbiota in a mouse model of systemic autoimmunity","volume":"74","author":"Shirakashi","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041758","article-title":"A role for fungal beta-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice","volume":"201","author":"Yoshitomi","year":"2005","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-020-02369-8","article-title":"Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"22","author":"Choi","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"\u2018SMASH\u2019 recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","article-title":"Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases","volume":"184","author":"Ota","year":"2021","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad049","article-title":"Serum immune profiling in paediatric crohn\u2019s disease demonstrates stronger immune modulation with first-line infliximab than conventional therapy and pre-treatment profiles predict clinical response to both treatments","volume":"17","author":"Jongsma","year":"2023","journal-title":"J Crohns Colitis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01527-9","article-title":"Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis","volume":"24","author":"Smith","year":"2023","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.30163","article-title":"Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis","volume":"63","author":"Grandaunet","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2183\/pjab.86.588","article-title":"The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine","volume":"86","author":"Nakamura","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-023458","article-title":"IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19","volume":"40","author":"Kishimoto","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.autrev.2021.102884","article-title":"Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis","volume":"20","author":"Takeuchi","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"106640","DOI":"10.1016\/j.phrs.2022.106640","article-title":"Blocking the HGF-MET pathway induces resolution of neutrophilic inflammation by promoting neutrophil apoptosis and efferocytosis","volume":"188","author":"Felix","year":"2023","journal-title":"Pharmacol Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.21037\/atm.2018.04.42","article-title":"Current advances of targeting HGF\/c-Met pathway in gastric cancer","volume":"6","author":"Anestis","year":"2018","journal-title":"Ann Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1517\/13543784.2013.778972","article-title":"Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis","volume":"22","author":"Chakraborty","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00152","article-title":"Targeting the HGF\/MET axis in cancer therapy: challenges in resistance and opportunities for improvement","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001661","article-title":"Hepatocyte growth factor: new arsenal in the fights against renal fibrosis","volume":"70","author":"Liu","year":"2006","journal-title":"Kidney Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines3010149","article-title":"Recent progress and advances in HGF\/MET-targeted therapeutic agents for cancer treatment","volume":"3","author":"Zhang","year":"2015","journal-title":"Biomedicines"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.08.044","article-title":"Recent advances in the discovery of small molecule c-Met Kinase inhibitors","volume":"143","author":"Parikh","year":"2018","journal-title":"Eur J Med Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1718591\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:27:24Z","timestamp":1771925244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1718591\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2026.1718591"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1718591","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1718591"}}